James F. Meschia

40.2k total citations · 7 hit papers
291 papers, 14.2k citations indexed

About

James F. Meschia is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, James F. Meschia has authored 291 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Epidemiology, 118 papers in Pulmonary and Respiratory Medicine and 117 papers in Neurology. Recurrent topics in James F. Meschia's work include Acute Ischemic Stroke Management (119 papers), Cerebrovascular and Carotid Artery Diseases (101 papers) and Cerebrovascular and genetic disorders (47 papers). James F. Meschia is often cited by papers focused on Acute Ischemic Stroke Management (119 papers), Cerebrovascular and Carotid Artery Diseases (101 papers) and Cerebrovascular and genetic disorders (47 papers). James F. Meschia collaborates with scholars based in United States, United Kingdom and Canada. James F. Meschia's co-authors include Thomas G. Brott, Seemant Chaturvedi, Virginia J. Howard, Wesley S. Moore, Larry B. Goldstein, Mark A. Creager, Cheryl Bushnell, Lynne T. Braun, Edward C. Jauch and Robert H. Eckel and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

James F. Meschia

279 papers receiving 13.8k citations

Hit Papers

Guidelines for the Primar... 2010 2026 2015 2020 2014 2021 2015 2010 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the Primary Prevention of Stroke
    2014 1.6k citations James F. Meschia, Cheryl Bushnell et al. Stroke profile →
  2. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
    2021 1.6k citations Dawn Kleindorfer, Seemant Chaturvedi et al. Stroke profile →
  3. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
    2015 1.6k citations William J. Powers, Colin P. Derdeyn et al. Stroke profile →
  4. Guidelines for the Primary Prevention of Stroke
    2010 962 citations Larry B. Goldstein, Cheryl Bushnell et al. Stroke profile →
  5. Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
    2011 608 citations Larry B. Goldstein, Cheryl Bushnell et al. Stroke profile →
  6. Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis
    2016 450 citations Thomas G. Brott, George Howard et al. profile →
  7. CNS small vessel disease
    2019 414 citations Mohammed K. Badi, Benjamin H. Eidelman et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James F. Meschia United States 45 6.1k 5.4k 4.6k 3.8k 1.4k 291 14.2k
Georgios Tsivgoulis Greece 61 7.9k 1.3× 4.5k 0.8× 3.2k 0.7× 5.5k 1.4× 1.9k 1.4× 641 15.1k
Philip M. Bath United Kingdom 70 7.8k 1.3× 3.9k 0.7× 4.5k 1.0× 3.9k 1.0× 2.1k 1.5× 457 18.1k
Cheryl Bushnell United States 52 5.6k 0.9× 2.9k 0.5× 3.9k 0.8× 3.1k 0.8× 1.9k 1.4× 186 14.2k
Steven J. Kittner United States 59 5.6k 0.9× 4.5k 0.8× 5.6k 1.2× 2.3k 0.6× 1.2k 0.8× 139 15.1k
Brett Kissela United States 66 7.5k 1.2× 2.8k 0.5× 3.8k 0.8× 4.0k 1.0× 3.4k 2.5× 266 15.2k
Dawn Kleindorfer United States 61 9.5k 1.6× 4.0k 0.7× 4.3k 0.9× 4.7k 1.2× 3.2k 2.4× 252 16.7k
Seemant Chaturvedi United States 43 7.4k 1.2× 7.1k 1.3× 5.5k 1.2× 3.9k 1.0× 1.0k 0.7× 217 13.3k
José Álvarez‐Sabín Spain 65 7.9k 1.3× 4.3k 0.8× 1.8k 0.4× 4.6k 1.2× 1.5k 1.1× 250 13.2k
Kazuo Minematsu Japan 56 6.7k 1.1× 3.9k 0.7× 3.2k 0.7× 3.8k 1.0× 1.5k 1.1× 456 12.1k
Walter N. Kernan United States 38 4.9k 0.8× 4.2k 0.8× 4.2k 0.9× 1.7k 0.4× 1.0k 0.8× 96 16.7k

Countries citing papers authored by James F. Meschia

Since Specialization
Citations

This map shows the geographic impact of James F. Meschia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Meschia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Meschia more than expected).

Fields of papers citing papers by James F. Meschia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Meschia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Meschia. The network helps show where James F. Meschia may publish in the future.

Co-authorship network of co-authors of James F. Meschia

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Meschia. A scholar is included among the top collaborators of James F. Meschia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Meschia. James F. Meschia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meschia, James F., Brajesh K. Lal, Ronald M. Lazar, & Thomas G. Brott. (2024). Unstable plaque is a treatable cause of cognitive decline. Medical Hypotheses. 190. 111423–111423. 1 indexed citations
2.
Salem, Amr, Demilade Adedinsewo, Mutlu Demirer, et al.. (2024). Differential associations between abnormal cardiac left ventricular geometry types and cerebral white matter disease. Journal of Stroke and Cerebrovascular Diseases. 33(6). 107709–107709.
3.
4.
5.
English, Stephen, et al.. (2024). Association between heart failure and cerebral collateral flow in large vessel occlusive ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 33(11). 107999–107999.
6.
Lin, Michelle, Mutlu Demirer, Erik H. Middlebrooks, et al.. (2023). Greater burden of white matter lesions and silent infarcts ipsilateral to carotid stenosis. Journal of Stroke and Cerebrovascular Diseases. 32(9). 107287–107287. 2 indexed citations
7.
Ghaith, Abdul Karim, Victor Gabriel El-Hajj, Elena Greco, et al.. (2023). Extracranial-Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Outcomes – A National Inpatient Sample Analysis. World Neurosurgery. 182. e624–e634. 2 indexed citations
8.
Sakusic, Amra, Baibing Chen, Mohammed K. Badi, et al.. (2023). Balamuthia mandrillarisEncephalitis Presenting as a Symptomatic Focal Hypodensity in an Immunocompromised Patient. Open Forum Infectious Diseases. 10(3). ofad094–ofad094. 1 indexed citations
9.
Dichgans, Martin & James F. Meschia. (2022). Advances in Stroke: Genetics, Genomics, Precision Medicine. Stroke. 53(10). 3211–3213. 1 indexed citations
10.
Lin, Michelle, Thomas G. Brott, David S. Liebeskind, et al.. (2020). Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease. Stroke. 51(5). 1404–1410. 43 indexed citations
11.
Lin, Michelle, James F. Meschia, Kevin M. Barrett, et al.. (2020). Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 30(3). 105581–105581. 11 indexed citations
12.
Badi, Mohammed K., George K. Vilanilam, Vivek Gupta, et al.. (2019). Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds. Journal of Stroke and Cerebrovascular Diseases. 28(8). 2159–2167. 7 indexed citations
13.
Tipton, Philip W., Kevin M. Barrett, Benjamin H. Eidelman, et al.. (2019). Incorporation of Telestroke into Neurology Residency Training: “Time Is Brain and Education”. Telemedicine Journal and e-Health. 26(8). 1035–1042. 11 indexed citations
14.
Marshall, Randolph S., Ronald M. Lazar, David S. Liebeskind, et al.. (2018). Carotid revascularization and medical management for asymptomatic carotid stenosis – Hemodynamics (CREST-H): Study design and rationale. International Journal of Stroke. 13(9). 985–991. 33 indexed citations
15.
Howard, Virginia J., Monika M. Safford, Suzanne E. Judd, et al.. (2016). Stroke Symptoms as a Predictor of Future Hospitalization. Journal of Stroke and Cerebrovascular Diseases. 25(3). 702–709. 6 indexed citations
16.
Powers, William J., Colin P. Derdeyn, José Biller, et al.. (2015). 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke. 46(10). 3020–3035. 1554 indexed citations breakdown →
17.
Voeks, Jenifer H., George Howard, Gary S. Roubin, et al.. (2011). Age and Outcomes After Carotid Stenting and Endarterectomy. Stroke. 42(12). 3484–3490. 176 indexed citations
18.
19.
Matarín, Mar, Javier Simón‐Sánchez, Hon‐Chung Fung, et al.. (2008). Structural genomic variation in ischemic stroke. Neurogenetics. 9(2). 101–108. 21 indexed citations
20.
Worrall, Bradford B., Devin L. Brown, Thomas G. Brott, et al.. (2003). Spouses and Unrelated Friends of Probands as Controls for Stroke Genetics Studies. Neuroepidemiology. 22(4). 239–244. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgios Tsivgoulis Breakdown of academic impact, for papers by Philip M. Bath Breakdown of academic impact, for papers by Cheryl Bushnell Breakdown of academic impact, for papers by Steven J. Kittner Breakdown of academic impact, for papers by Brett Kissela Breakdown of academic impact, for papers by Dawn Kleindorfer Breakdown of academic impact, for papers by Seemant Chaturvedi Breakdown of academic impact, for papers by José Álvarez‐Sabín Breakdown of academic impact, for papers by Kazuo Minematsu Breakdown of academic impact, for papers by Walter N. Kernan
Rankless by CCL
2026